Literature DB >> 21197374

Specific treatment of residual fatigue in depressed patients.

Humberto Marin1, Matthew A Menza.   

Abstract

Entities:  

Year:  2004        PMID： 21197374      PMCID： PMC3012615     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  52 in total

1.  Delineating psychopathologic clusters within dysthymia: a study of 512 out-patients without major depression.

Authors:  A Serretti; M C Jori; G Casadei; L Ravizza; E Smeraldi; H Akiskal
Journal:  J Affect Disord       Date:  1999-11       Impact factor: 4.839

Review 2.  Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists.

Authors:  H Wolf
Journal:  Scand J Rheumatol Suppl       Date:  2000

3.  Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease.

Authors:  Stig Andersen; Klaus Michael Pedersen; Niels Henrik Bruun; Peter Laurberg
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  Effects of cognitive therapy on psychological symptoms and social functioning in residual depression.

Authors:  J Scott; J D Teasdale; E S Paykel; A L Johnson; R Abbott; H Hayhurst; R Moore; A Garland
Journal:  Br J Psychiatry       Date:  2000-11       Impact factor: 9.319

5.  Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.

Authors:  P Powell; R P Bentall; F J Nye; R H Edwards
Journal:  BMJ       Date:  2001-02-17

6.  Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program.

Authors:  A Dryman; W W Eaton
Journal:  Acta Psychiatr Scand       Date:  1991-07       Impact factor: 6.392

7.  Effects of treatment for depression on fatigue in multiple sclerosis.

Authors:  David C Mohr; Stacey L Hart; Alison Goldberg
Journal:  Psychosom Med       Date:  2003 Jul-Aug       Impact factor: 4.312

8.  Neurasthenia: prevalence, disability and health care characteristics in the Australian community.

Authors:  Ian Hickie; Tracey Davenport; Cathy Issakidis; Gavin Andrews
Journal:  Br J Psychiatry       Date:  2002-07       Impact factor: 9.319

9.  A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome.

Authors:  L G Olson; A Ambrogetti; D C Sutherland
Journal:  Psychosomatics       Date:  2003 Jan-Feb       Impact factor: 2.386

10.  Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.

Authors:  Charles DeBattista; Karl Doghramji; Matthew A Menza; Murray H Rosenthal; Ronald R Fieve
Journal:  J Clin Psychiatry       Date:  2003-09       Impact factor: 4.384
View more
  6 in total

Review 1.  Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  BMC Med       Date:  2015-02-06       Impact factor: 8.775

2.  Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions.

Authors:  Thorsten Rudroff; John H Kindred; Nathaniel B Ketelhut
Journal:  Front Neurol       Date:  2016-08-02       Impact factor: 4.003

3.  Finding factors that predict treatment-resistant depression: Results of a cohort study.

Authors:  M Soledad Cepeda; Jenna Reps; Patrick Ryan
Journal:  Depress Anxiety       Date:  2018-05-22       Impact factor: 6.505

4.  Gene expression profile associated with Asmt knockout-induced depression-like behaviors and exercise effects in mouse hypothalamus.

Authors:  Wenbin Liu; Weina Liu; Zhuochun Huang; Jie Xia; Zhiming Cui; Lingxia Li; Zhengtang Qi
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 5.  Understanding Fatigue in Sjögren's Syndrome: Outcome Measures, Biomarkers and Possible Interventions.

Authors:  Elisabeth Mæland; Samira T Miyamoto; Daniel Hammenfors; Valeria Valim; Malin V Jonsson
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

6.  Moxibustion at 'Danzhong' (RN17) and 'Guanyuan' (RN4) for fatigue symptom in patients with depression: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Somayeh Iravani; Liwei Cai; Lue Ha; Shuzhe Zhou; Chuan Shi; Yibin Ma; Qin Yao; Ke Xu; Baixiao Zhao
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.